Alpha-caryophyllene synthetase AoHS1 from alpinia oxyphylla and application thereof
By characterizing α-caryophyllene synthase AoHS1 from Alpinia oxyphylla and expressing it in Saccharomyces cerevisiae, the method addresses the limitations of plant extraction by achieving efficient and cost-effective microbial synthesis of caryophyllene.
Patent Information
- Application Number
- CN202411196347.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-29
- Publication Date
- 2024-12-06
AI Technical Summary
The production of caryophyllene from plant extraction is limited by factors such as climate, yield, and cost, leading to high prices, and there is a lack of identified α-caryophyllene synthases for microbial biosynthesis.
Identification and functional characterization of α-caryophyllene synthase AoHS1 from Alpinia oxyphylla, which is used to construct a recombinant expression vector and express it in Saccharomyces cerevisiae, catalyzing the synthesis of α-caryophyllene and β-caryophyllene from farnesyl pyrophosphate.
The method enables efficient microbial synthesis of α-caryophyllene and β-caryophyllene, reducing production costs and providing a sustainable alternative to plant extraction.
Smart Images

Figure CN119082092A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of terpene biosynthesis, and specifically relates to an alpha-caryophyllene synthase AoHS1 derived from Alpinia oxyphylla and an application thereof. Background Art
[0002] Alpinia oxyphylla Miq., also known as Alpinia oxyphylla, Alpinia oxyphylla, is a herbaceous plant of the Zingiberaceae family. Essential oils extracted from different parts of the fruit of Alpinia oxyphylla are an important component that contains a variety of natural compounds and has a variety of medicinal values. So far, the main compounds found in Alpinia oxyphylla are terpenes, phenols and sterols, among which terpenes are the important components isolated and identified from the fruit of Alpinia oxyphylla.
[0003] Terpenoids are one of the most numerous and diverse secondary metabolites in plants. Their basic unit is isoprene (C5H8). According to the amount of isoprene, terpenoids are divided into hemiterpenes (C5), monoterpenes (C10), sesquiterpenes (C15), diterpenes (C20), dipterpenes (C25), triterpenes (C30), tetraterpenes (C40) and polyterpenes. Studies have shown that terpenoids have a wide range of uses in actual production and have been developed into natural flavors, fuels, food additives, therapeutic agents, metabolic regulators and pesticides. In addition, clinical studies have shown that some terpenes have pharmacological effects such as neuroprotection, memory enhancement, antibacterial and anti-inflammatory, respiratory function improvement, cardiac stimulation, and sedative hypnosis.
[0004] Caryophyllene is a sesquiterpenoid compound that has been used in the pharmaceutical industry due to its anti-inflammatory and anti-cancer biological activities. Currently, the production of caryophyllene mainly comes from plant extraction, but the plant extraction method is limited by factors such as climate, yield, and cost, resulting in high prices. With the rapid development of synthetic biology, the production of caryophyllene by microorganisms is considered to be a green and sustainable production method. Caryophyllene synthase is a key enzyme in the caryophyllene synthesis pathway, which can catalyze the substrate farnesyl pyrophosphate (FPP) to produce caryophyllene. The microbial biosynthesis method requires the introduction of the key enzyme α-caryophyllene synthase / β-caryophyllene synthase in the synthesis pathway. The number of α-caryophyllene synthase / β-caryophyllene synthases that have been identified is limited, so more enzymes need to be discovered for researchers to use. Summary of the invention
[0005] In order to overcome the shortcomings and deficiencies of the prior art, the object of the present invention is to provide a new α-caryophyllene synthase AoHS1 derived from Alpinia oxyphylla and its application.
[0006] The present invention provides an α-caryophyllene synthase AoHS1 derived from Alpinia oxyphylla. AoHS1 contains a conserved sequence DD××D rich in aspartic acid that is unique to terpene synthases. The amino acid sequence of AoHS1 and α-caryophyllene synthase ZSS1 derived from Zingiber officinale is compared by BLAST. It is found that the sequence similarity between AoHS1 and ZSS1 is 83.3% ( Figure 3 ). The amino acid sequence of ZSS1 is shown as B1B1U3.1, and the nucleotide sequence is shown as AB247331.1. The present invention functionally characterizes α-caryophyllene synthase AoHS1, and provides the application of AoHS1 in the synthesis of caryophyllene by Saccharomyces cerevisiae.
[0007] The purpose of the present invention is achieved through the following technical solutions:
[0008] An alpha-caryophyllene synthase AoHS1 derived from Alpinia oxyphylla, whose amino acid sequence is shown in SEQ ID NO.2.
[0009] A gene encoding the α-caryophyllene synthase AoHS1, preferably, its nucleotide sequence is shown as SEQ ID NO.1.
[0010] The gene can give the seeds of Alpinia oxyphylla a sesquiterpene α-caryophyllene component. The gene sequence contains a conserved sequence DD××D rich in aspartic acid that is unique to terpene synthases, and belongs to plant terpene synthases. It has the highest similarity with the sesquiterpene synthase α-caryophyllene synthase from the ginger plant Zingiber officinale in the database, and the amino acid sequence similarity is 83.3%.
[0011] The above-mentioned biological material related to α-caryophyllene synthase AoHS1 is any one or more combinations of the following biological materials:
[0012] (a) an expression cassette containing the above encoding gene;
[0013] (b) a recombinant expression vector containing the above encoding gene;
[0014] (c) a recombinant expression vector containing the expression cassette described in (a);
[0015] (d) a recombinant microorganism containing the above encoding gene;
[0016] (e) a recombinant microorganism containing the expression cassette described in (a);
[0017] (f) A recombinant microorganism containing the recombinant expression vector described in (b) or (c).
[0018] Furthermore, the expression cassette in (a) further comprises a promoter and a terminator; the promoter is promoter CCW12 (CCW12 p) etc., wherein the terminator is the terminator CYC1 (CYC1 t )wait.
[0019] Furthermore, the starting vector of the recombinant expression vector in (b) and (c) is a YEp-type vector, etc.; preferably, it is a YEp352 vector.
[0020] Furthermore, the host microorganism corresponding to the recombinant microorganism in (d), (e), and (f) is selected from prokaryotes or yeasts, etc.; the prokaryotes include bacteria such as Escherichia; the yeasts include yeasts such as Saccharomyces cerevisiae. More specifically, the prokaryotes are Escherichia coli (E.coli), which can be specifically Escherichia coli BL21 (DE3); the yeast is Saccharomyces cerevisiae CEN.PK2-1Ca strain, or a recombinant Saccharomyces cerevisiae producing the precursor substance FPP constructed using the Saccharomyces cerevisiae CEN.PK2-1Ca strain as the starting strain.
[0021] Preferably, a method for constructing a recombinant Saccharomyces cerevisiae strain comprises the following steps: cloning a gene encoding an α-caryophyllene synthase AoHS1 having an amino acid sequence as shown in SEQ ID No. 2 into an expression vector to obtain a recombinant expression vector, and transforming the recombinant expression vector into a host cell Saccharomyces cerevisiae to construct a recombinant Saccharomyces cerevisiae strain.
[0022] Preferably, the expression vector is a YEp352 vector; the host cell Saccharomyces cerevisiae is a Saccharomyces cerevisiae CEN.PK2-1Ca strain, or a recombinant Saccharomyces cerevisiae producing the precursor substance FPP constructed using the Saccharomyces cerevisiae CEN.PK2-1Ca strain as a starting strain.
[0023] The use of the above-mentioned α-caryophyllene synthase AoHS1, encoding gene or α-caryophyllene synthase AoHS1 related biological materials in the preparation of α-caryophyllene synthase AoHS1.
[0024] Application of the above-mentioned α-caryophyllene synthase AoHS1, encoding gene or biological materials related to α-caryophyllene synthase AoHS1 in the preparation of α-caryophyllene and / or β-caryophyllene.
[0025] Furthermore, the above-mentioned α-caryophyllene synthase AoHS1, encoding gene or biological materials related to α-caryophyllene synthase AoHS1 are used in the biosynthesis of α-caryophyllene and / or β-caryophyllene.
[0026] The application is: using farnesyl pyrophosphate (FPP) as a substrate, and catalyzing α-caryophyllene synthase AoHS1 to produce α-caryophyllene and β-caryophyllene.
[0027] Further, the fermentation medium for producing α-caryophyllene and β-caryophyllene is SD-ΔUra medium: 20 g / L glucose, 6.7 g / L YNB, 0.62 g / L DO Supplement (Δura-Δtrp-Δleu), 0.06 g / L leucine, 0.04 g / L tryptophan, 20% (V / V) n-dodecane is added for biphasic fermentation, and the fermentation conditions are: fermentation time 48h, fermentation temperature 30°C. The fermentation product is detected by gas chromatography, and GC-MS is further used to assist in the identification of unknown fermentation products.
[0028] Compared with the prior art, the present invention has the following advantages and effects:
[0029] The present invention has excavated an unreported α-caryophyllene synthase AoHS1 from the source of Alpinia oxyphylla and has functionally characterized it, constructed a recombinant expression vector containing the gene, and heterologously expressed it in a saccharomyces cerevisiae strain. The main product α-caryophyllene can be synthesized by catalyzing the farnesyl pyrophosphate FPP substrate, and a small amount of β-caryophyllene can also be produced. The fermentation product is identified by GC-MS to contain sesquiterpene compounds α-caryophyllene and β-caryophyllene, and its yield shows that the α-caryophyllene synthase AoHS1 has a stronger catalytic ability than the reported α-caryophyllene synthase ZSS1 from red ginger. Therefore, the present invention can realize the efficient synthesis of α-caryophyllene and β-caryophyllene in microbial cells, effectively reduce production costs, and is conducive to the efficient production of α-caryophyllene and β-caryophyllene, and provides technical support for the heterologous preparation of terpene compounds α-caryophyllene and β-caryophyllene using synthetic biology methods. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 This is the agarose gel electrophoresis diagram of RNA extracted from Alpinia oxyphylla seeds.
[0031] Figure 2 The expression specificity of the AoHS1 gene of the present invention in different tissues of Alpinia oxyphylla fruit; S: seed; P: peel.
[0032] Figure 3 This is the comparison result of the amino acid sequences of AoHS1 and ZSS1 of the present invention.
[0033] Figure 4 The AoHS1 gene was amplified from the cDNA of Alpinia oxyphylla seeds.
[0034] Figure 5 This is a map of the recombinant expression plasmid YEp352-AoHS1 of Saccharomyces cerevisiae of the present invention.
[0035] Figure 6These are the GC-MS identification results of the fermentation products of the heterologously expressed AoHS1 gene in Saccharomyces cerevisiae; wherein, A: gas chromatogram of the fermentation products of PL00-AoHS1 and PL00-ZSS1; B: mass spectrometry identification result of peak 1 of PL00-AoHS1; C: mass spectrometry identification result of peak 2 of PL00-AoHS1. DETAILED DESCRIPTION
[0036] The present invention is further described in detail below in conjunction with embodiments and drawings, but the embodiments of the present invention are not limited thereto.
[0037] The experimental methods in the following examples without specific experimental conditions are usually carried out under conventional experimental conditions or the experimental conditions recommended by the manufacturer. The materials and reagents used are commercially available unless otherwise specified.
[0038] Example 1 Obtaining the full-length cDNA of AoHS1 gene
[0039] S1. Extraction of RNA from Alpinia oxyphylla seeds: Fresh Alpinia oxyphylla fruits were picked and the peel and seeds were separated as soon as possible. After quick freezing with liquid nitrogen, they were stored in a -80°C ultra-low temperature refrigerator. After analysis, the relative expression level of the AoHS1 gene in the Alpinia oxyphylla seeds was higher than that in the peel ( Figure 2 ). Subsequently, the seeds of Alpinia oxyphylla were used as materials for RNA extraction. The pipette tips and Eppendorf tubes used for RNA extraction were soaked in 0.1% DEPC at 37°C overnight and sterilized at 121°C for 25 minutes. The glassware and mortar were wrapped in aluminum foil and dry-heat treated at 180°C for 3 hours. They were cooled and set aside. The total RNA of Alpinia oxyphylla seeds was extracted using the RNA extraction kit of Novozymes. The integrity of RNA was detected by 1% agarose gel electrophoresis ( Figure 1 ), and use a multifunctional microplate reader to determine its concentration and purity. Store at -80℃ for future use. The extracted RNA has three uses: 1. For transcriptome sequencing analysis; 2. For Q-PCR experiments; 3. For amplification of target genes after reverse transcription.
[0040] S2. Total RNA from Alpinia oxyphylla seeds was used as a template to synthesize the first-strand cDNA using the Novozymes HiScript III 1st Strand cDNA Synthesis Kit (+gDNA wiper). The reaction conditions and system are as follows: 1.
[0042] Reagents Dosage Total RNA 10pg-5μg <![CDATA[RNase-free ddH2O]]> Up to 8μL
[0043] Heat at 65°C for 5 min, quickly cool on ice, and keep on ice for 2 min. 2.
[0045] Reagents Dosage The mixture from the previous step 8μL 5×gDNAwiper mix 2μL
[0046] Incubate at 42°C for 5 min. 3.
[0048]
[0049] The reverse transcribed cDNA was used as a PCR template, and primers were designed based on the annotated gene sequences of the Alpinia oxyphylla transcriptome data. The sequences are as follows:
[0050] Upstream primer F1: 5′-ATGGAGAGGCCGTCGATC-3′;
[0051] Downstream primer R1: 5′-TTAAATACTTAAAGATTCAACCAATAGG-3′;
[0052] The 5' ends of the upstream and downstream primers carry sequences that are consistent with the two ends of the linearized vector. Therefore, the primers for amplifying the target gene during the construction of the recombinant expression vector are as follows (the underlined sequences are bases homologous to the vector to be connected):
[0053] Upstream primer F2: 5'- AACACTATATCAATATCTA ATGGAGAGGCCGTCGATC-3′;
[0054] Downstream primer R2: 5'- ACTAATTACATGATGCGGC TTAAATACTTAAAGATTCAACCAATAGG-3';
[0055] The cDNA was synthesized by Shanghai Bioengineering Co., Ltd. The TaKaRa PCR Amplification Kit was used to perform PCR amplification reaction using the above synthesized cDNA as a template. The specific reaction conditions and system are as follows:
[0056]
[0057] After the PCR reaction was completed, 1.0% agarose gel electrophoresis was used to preliminarily detect whether the PCR product contained the target fragment band. Figure 4 After confirming that the band size was correct, the PCR product was recovered using HiPure PCR Pure Mini Kit (Magen), and then its concentration and purity were determined using a multifunctional microplate reader.
[0058] Among them, the nucleotide sequence of the AoHS1 gene is shown as SEQ ID NO.1, and the encoded amino acid sequence is shown as SEQ ID NO.2.
[0059] Example 2 Construction of recombinant expression plasmids YEp352-AoHS1 and YEp352-ZSS1
[0060] First, the template plasmid YEp352-CCW12 p -CYC1 t (Shuttle plasmid, 2μ, URA, Addgene, USA, containing promoter CCW12 and terminator CYC1) was linearized by PCR amplification to obtain a linearized vector; the sequences of the PCR primers used are as follows:
[0061] Upstream primer F3: 5′-GCCGCATCATGTAATTAGTT-3′;
[0062] Downstream primer R3: 5′-TAGATATTGATATAGTGTTTAAGCG-3′;
[0063] The gene sequence of α-caryophyllene synthase ZSS1 from Zingiber zerumbet is shown as AB247331.1, and its amino acid sequence is shown as B1B1U3.1. The ZSS1 gene was synthesized by GenScript Biotech Co., Ltd., and the ZSS1 gene with homology arm sequence was amplified by the following primers:
[0064] Upstream primer F4: 5'- AACACTATATCAATATCTA ATGGAGAGGCAGTCGATG-3′;
[0065] Downstream primer R4: 5'- ACTAATTACATGATGCGGC TTAAATAAGAAAGGATTC-3';
[0066] The PCR product (AoHS1 gene) with vector end sequences at both ends obtained in Example 1 or the ZSS1 gene with homology arm sequences and the linearized vector were mixed in a certain proportion and reacted at 37° C. for 30 minutes under the catalysis of recombinase Exnase II.
[0067] The reaction conditions and system are as follows:
[0068] Reagents Dosage ExnaseⅡ 1μL 5×Buffer CE II 2μL vector (Large fragment length × 0.01) / Large fragment concentration segment (Small fragment length × 0.02) / Small fragment concentration <![CDATA[ddH2O]]> Up to 10μL
[0069] After cooling 10 μL of the recombinant product on ice, directly transform it into E. coli DH5α competent cells, flick the tube wall to mix, and place it on ice for 30 minutes. After heat shock in a 42°C water bath for 90 seconds, immediately place it on ice to cool for 2-3 minutes. Add 800 μL LB medium (without antibiotics) and shake the bacteria at 37°C for 1 hour (speed 220 rpm). Centrifuge at 5,000 rpm for 3 minutes and discard 650 μL of supernatant. Resuspend the bacteria with the remaining medium and spread it on LB / Amp with a sterile spreader. +Gently spread the plate evenly, then invert and culture in a 37°C incubator for 12-16 hours. Pick a single clone and incubate in LB / Amp + Patch the plate and culture for 5-6 hours. Use colony PCR technology to screen the single clones. Pick 3-5 single colonies in the clean bench and dissolve them in 20μL ddH2O. Heat lyse at 95℃ for 10 minutes. Centrifuge at 3000rpm for 2 minutes. The supernatant obtained can be used as the template for colony PCR. The reaction system and conditions of colony PCR are as follows:
[0070]
[0071] The primers for colony PCR are as follows:
[0072] Upstream primer F5: 5′-CCTACATTGTTCTAATTATTC-3′;
[0073] Downstream primer R5: 5′-CTGTTGTATGTAGCTAACAATACAT-3′;
[0074] For colonies identified as positive by colony PCR, strains corresponding to the band size can be selected and inoculated into LB / Amp + The cells were cultured overnight at 37°C and 220 rpm in liquid culture medium, and the plasmid was extracted using HiPure Plasmid Micro Kit (Magen) to obtain the recombinant expression plasmid YEp352-CCW12. p -AoHS1-CYC1 t (abbreviated as YEp352-AoHS1) (plasmid map see Figure 5 )、YEp352-CCW12 p -ZSS1-CYC1 t (abbreviated as YEp352-ZSS1). p -AoHS1-CYC1 t or YEp352-CCW12 p -ZSS1-CYC1 t Inserted between the SacI and HindⅢ restriction sites of YEp352 plasmid.
[0075] Example 3 Construction of recombinant Saccharomyces cerevisiae strains and identification of fermentation products
[0076] S1. Preparation of Saccharomyces cerevisiae competent cells PL00
[0077] Activate the PL00 strain stored at -80°C by streaking on a YPD plate, pick a single colony and inoculate it into 5 mL of YPD liquid medium, and culture it in a constant temperature shaker at 30°C and 200 rpm for 12 to 16 h until the OD 600 When the value grows to between 3.0 and 5.0, take a certain amount of bacterial solution and transfer it to a new 5 mL YPD liquid medium to control the initial OD 600 The temperature was 0.2-0.4, and cultured at 30°C and 220 rpm for about 4-6 h. The final OD 600 It should be controlled at 0.8-1.0. Use the kit to prepare yeast competent cells: take 1mL of bacterial solution in a 1.5mL centrifuge tube, centrifuge at 7000rpm for 3min, and discard the supernatant. Take 1mL of SolutionⅠ to resuspend the bacteria, centrifuge at 7000rpm for 3min, and discard the supernatant. Take 100μL of SolutionⅡ to resuspend the bacteria. At this time, yeast competent cells are obtained. After packaging in 25μl / tube, plasmid transformation can be performed immediately or stored at -80℃.
[0078] Among them, the construction of the PL00 strain: using the technology described in patent application No. 201910271558.6, the host cell ScCEN.PK2-1Ca was genome-modified, that is, the restriction factor rox1 of the mevalonate pathway was knocked out, and the expression intensity of the downstream branch pathway-related enzyme erg9 of the sesquiterpenoid precursor FPP was down-regulated to increase the supply of the precursor FPP, and finally the ScPK2-M strain was obtained. On the basis of the ScPK2-M strain, the method in the document "Chen Hefeng. Construction and metabolic engineering transformation of Valencia ene cell factory [D]. South China University of Technology, 2019." was further used to increase the expression intensity of erg12 and tHMG1, and finally the ScPK2-01 strain was obtained. Based on the ScPK2-01 strain, the method in the literature "Liu T, Li W, Chen H, et al. Systematic Optimization of HPO-CPR to Boost (+)-Nootkatone Synthesis in Engineered Saccharomyces cerevisiae [J]. Journal of agricultural and food chemistry, 2022, 70 (49): 15548-15559. DOI: 10.1021 / acs.jafc.2c07068." was further used to overexpress ICE2 and INO2, and finally the PL00 strain was obtained.
[0079] S2. Transformation of recombinant expression plasmids YEp352-AoHS1 and YEp352-ZSS1 into Saccharomyces cerevisiae competent cells
[0080] Take out a tube of competent Saccharomyces cerevisiae cells (25 μL), add 500 ng of the recombinant expression plasmid to the competent cells, and then add 250 μL of Solution III. After mixing, vortex and shake for 10 seconds, then culture at 30°C for 15 minutes, incubate for 1 hour, and repeat this process 4 times. Spread the entire bacterial solution on SD-ΔUra plates (20 g / L glucose, 6.7 g / L YNB, 0.62 g / L DO Supplement (△ura-△trp-△leu), 0.06 g / L leucine, 0.04 g / L tryptophan), culture at 30°C for 2-3 days until a single clone grows, that is, the recombinant plasmid is integrated into the Saccharomyces cerevisiae strain to obtain the recombinant strains PL00-AoHS1 and PL00-ZSS1.
[0081] S3. Shake flask fermentation of recombinant strains PL00-AoHS1 and PL00-ZSS1 to detect α-caryophyllene and β-caryophyllene
[0082] Single colonies of the recombinant strains PL00-AoHS1 and PL00-ZSS1 were picked and inoculated into 5 mL SD-ΔUra liquid medium. After culturing for 12-16 hours, they were transferred to shake flasks (10 mL SD-ΔUra liquid medium) to control the initial OD 600 The temperature was 0.05, 2 mL of n-dodecane was added to cover, and the culture was carried out at 220 rpm and 30 °C for 48 h. After the fermentation was completed, the upper organic phase was completely removed and the OD of the bacterial solution was measured. 600 The organic phase was filtered through a 0.22 μm nylon organic membrane. GC detection revealed that the fermentation product of PL00-ZSS1 had a chromatographic peak at 14 min and 15 min respectively ( Figure 6 A), according to the reported literature, they are β-caryophyllene and α-caryophyllene, and the fermentation product of PL00-AoHS1 also has these two chromatographic peaks at the same retention time ( Figure 6 A), and the fermentation products of PL00-AoHS1 were identified as β-caryophyllene and α-caryophyllene by GC-MS ( Figure 6 B, C). By establishing the gas chromatography standard curves of β-caryophyllene and α-caryophyllene, it was found that the α-caryophyllene yield of PL00-ZSS1 was 337 mg / L, the β-caryophyllene yield was 24.8 mg / L, and the α-caryophyllene yield of PL00-AoHS1 was 339 mg / L, the β-caryophyllene yield was 38 mg / L.
[0083] GC detection conditions: Agilent HP-5 (30m×0.32mm×0.25μm) chromatographic column, carrier gas is nitrogen, carrier gas flow rate is 2.3ml / min. Split ratio is 15:1, and the heating program is as follows:
[0084] Heating rate temperature time 100℃ 10min 8℃ / min 150℃ 0min 30℃ / min 250℃ 3min
[0085] The above embodiments are preferred implementation modes of the present invention, but the implementation modes of the present invention are not limited to the above embodiments. Any other changes, modifications, substitutions, combinations, and simplifications that do not deviate from the spirit and principles of the present invention should be equivalent replacement methods and are included in the protection scope of the present invention.
Claims
1. An α-caryophyllene synthase AoHS1 derived from Alpinia oxyphylla, characterized in that: The amino acid sequence of the α-caryophyllene synthase AoHS1 is shown in SEQ ID NO.
2.
2. A gene encoding the α-caryophyllene synthase AoHS1 derived from the Alpinia oxyphylla of claim 1.
3. The gene according to claim 2, characterized in that: The nucleotide sequence of the gene is shown in SEQ ID NO.
1.
4. The biomaterial related to α-caryophyllene synthase AoHS1 derived from Alpinia oxyphylla according to claim 1, characterized in that: Any one or more combinations of the following biological materials: (a) an expression cassette containing the gene according to claim 2 or 3; (b) a recombinant expression vector containing the gene according to claim 2 or 3; (c) a recombinant expression vector containing the expression cassette described in (a); (d) a recombinant microorganism containing the gene according to claim 2 or 3; (e) a recombinant microorganism containing the expression cassette described in (a); (f) A recombinant microorganism containing the recombinant expression vector described in (b) or (c).
5. The biomaterial according to claim 4, characterized in that: The expression cassette in (a) further comprises a promoter and a terminator; the promoter is promoter CCW12, and the terminator is terminator CYC1; The starting vector of the recombinant expression vector in (b) and (c) is a YEp type vector; The host microorganism corresponding to the recombinant microorganisms in (d), (e) and (f) is selected from prokaryotes or yeast.
6. The biomaterial according to claim 5, characterized in that: The starting vector of the recombinant expression vector in (b) and (c) is YEp352 vector; The host microorganism corresponding to the recombinant microorganisms described in (d), (e) and (f) is the Saccharomyces cerevisiae CEN.PK2-1Ca strain, or a recombinant Saccharomyces cerevisiae producing the precursor substance FPP constructed using the Saccharomyces cerevisiae CEN.PK2-1Ca strain as the starting strain.
7. Use of the α-caryophyllene synthase AoHS1 according to claim 1, the gene according to any one of claims 2 to 3, or the biomaterial according to any one of claims 4 to 6 in the preparation of α-caryophyllene synthase AoHS1.
8. Use of the α-caryophyllene synthase AoHS1 according to claim 1, the gene according to any one of claims 2 to 3, or the biomaterial according to any one of claims 4 to 6 in the preparation of α-caryophyllene and / or β-caryophyllene.
9. Use of the α-caryophyllene synthase AoHS1 according to claim 1, the gene according to any one of claims 2 to 3, or the biomaterial according to any one of claims 4 to 6 in the biosynthesis of α-caryophyllene and / or β-caryophyllene.
10. The use according to claim 8 or 9, characterized in that: Farnesyl pyrophosphate (FPP) was used as substrate to produce α-caryophyllene and β-caryophyllene catalyzed by α-caryophyllene synthase AoHS1.
Citation Information
Patent Citations
Engineered Saccharomyces cerevisiae for producing Valenciaene, its construction method and application
CN110117551B
